Similar outcomes after haploidentical transplantation with post-transplant cyclophosphamide versus HLA-matched transplantation: a meta-analysis of case-control studies | Zendy

Zhenyang Gu | Zendy; Li Wang | Zendy; Lei Yuan | Zendy; Wenrong Huang | Zendy; Meng Li | Zendy; Lixun Guan | Zendy; Qingyi Wang | Zendy; Zhe Gao | Zendy; Shasha Zhao | Zendy; Lan Luo | Zendy; Feiyan Wang | Zendy; Nan Yang | Zendy; DaiHong Liu | Zendy; Jon C. Aster | Zendy; Chunji Gao | Zendy

Open Access

Similar outcomes after haploidentical transplantation with post-transplant cyclophosphamide versus HLA-matched transplantation: a meta-analysis of case-control studies

Author(s) -

Zhenyang Gu,

Li Wang,

Lei Yuan,

Wenrong Huang,

Meng Li,

Lixun Guan,

Qingyi Wang,

Zhe Gao,

Shasha Zhao,

Lan Luo,

Feiyan Wang,

Nan Yang,

DaiHong Liu,

Jon C. Aster,

Chunji Gao

Publication year - 2017

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.18862

Subject(s) - medicine , transplantation , hematopoietic cell , cyclophosphamide , oncology , hematology , chemotherapy , haematopoiesis , stem cell , biology , genetics

Outcomes of haploidentical hematopoietic cell transplantation (haplo-HCT) with post-transplant cyclophosphamide (PT-Cy) have greatly improved. It remains unknown whether haplo-HCT with PT-Cy was associated with poor outcomes when compared with HLA-matched HCT. To address this issue, we performed a meta-analysis to compare outcomes of haplo-HCT with PT-Cy with those of HLA-matched HCT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research